Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin
Crossref DOI link: https://doi.org/10.1007/s00280-017-3412-8
Published Online: 2017-08-11
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Blank, N.
Laskov, I.
Kessous, R.
Kogan, L.
Lau, S.
Sebag, I. A.
Gotlieb, Walter H.
Rudski, L.
License valid from 2017-08-11